Virtu Financial’s NRX Pharmaceuticals NRXP Stock Holding History

Virtu Financial’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68K	Sell	16,614 -15,171	-48%	-$50.1K	﹤0.01%	1175
2026 Q1	$68K	Buy	+31,785	New	+$64.2K	﹤0.01%	1242
2024 Q3	–	Sell	-17,043	Closed	-$42K	–	1715
2024 Q2	$42K	Buy	+17,043	New	+$60.6K	﹤0.01%	927
2023 Q2	–	Sell	-4,621	Closed	-$30K	–	1860
2023 Q1	$30K	Buy	+4,621	New	+$46.8K	﹤0.01%	1170
2022 Q3	–	Sell	-1,280	Closed	-$8K	–	2065
2022 Q2	$8K	Buy	+1,280	New	+$16.8K	﹤0.01%	1441
2022 Q1	–	Sell	-6,158	Closed	-$294K	–	1852
2021 Q4	$294K	Buy	+6,158	New	+$444K	0.03%	637
2018 Q1	–	Sell	-1,241	Closed	-$120K	–	2389
2017 Q4	$120K	Buy	+1,241	New	+$120K	0.01%	1858

Other funds holding NRXP

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Virtu Financial's NRXP Position: Q2 2026 in Review

Virtu Financial reduced its NRX Pharmaceuticals (NRXP) stake by 48% in Q2 2026, selling an estimated $50.1K and leaving 16,614 shares worth $68K. The position accounts for ﹤0.01% of the portfolio, ranked #1175.

Virtu Financial first reported a position in NRXP in Q4 2017 and has held it in 7 quarters since. The position peaked at $294K in Q4 2021. 47 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

Virtu Financial held 16,614 shares of NRX Pharmaceuticals worth $68K as of Q2 2026.
Virtu Financial sold 15,171 NRX Pharmaceuticals shares in Q2 2026, an estimated $50.1K.
NRX Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1175 holding.
Virtu Financial first reported a position in NRX Pharmaceuticals in Q4 2017 and has held it in 7 quarters since.
Virtu Financial's NRX Pharmaceuticals position peaked at $294K in Q4 2021.
47 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.